BALTIMORE--(BUSINESS WIRE)--Sept. 12, 2006--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today its financial results for the second quarter and six months ended June 30, 2006
